| Literature DB >> 31142645 |
Paulo S Caceres1, Diego Gravotta1, Patrick J Zager1, Noah Dephoure2, Enrique Rodriguez-Boulan3.
Abstract
The current model of polarized plasma membrane protein sorting in epithelial cells has been largely generated on the basis of experiments characterizing the polarized distribution of a relatively small number of overexpressed model proteins under various experimental conditions. Thus, the possibility exists that alternative roles of various types of sorting machinery may have been underestimated or missed. Here, we utilize domain-selective surface biotinylation combined with stable isotope labeling with amino acids in cell culture (SILAC) and mass spectrometry to quantitatively define large populations of apical and basolateral surface proteins in Madin-Darby canine kidney (MDCK) cells. We identified 313 plasma membrane proteins, of which 38% were apical, 51% were basolateral, and 11% were nonpolar. Silencing of clathrin adaptor proteins (AP) AP-1A, AP-1B, or both caused redistribution of basolateral proteins as expected but also, of a large population of apical proteins. Consistent with their previously reported ability to compensate for one another, the strongest loss of polarity was observed when we silenced AP-1A and AP-1B simultaneously. We found stronger evidence of compensation in the apical pathway compared with the basolateral pathway. Surprisingly, we also found subgroups of proteins that were affected after silencing just one adaptor, indicating previously unrecognized independent roles for AP-1A and AP-1B. While AP-1B silencing mainly affected basolateral polarity, AP-1A silencing seemed to cause comparable loss of apical and basolateral polarity. Our results uncover previously overlooked roles of AP-1 in polarized distribution of apical and basolateral proteins and introduce surface proteomics as a method to examine mechanisms of polarization with a depth not possible until now.Entities:
Keywords: AP-1A; AP-1B; SILAC mass spectrometry; apical basolateral polarity; epithelial polarity
Mesh:
Substances:
Year: 2019 PMID: 31142645 PMCID: PMC6575629 DOI: 10.1073/pnas.1821076116
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205
Fig. 1.Polarized surface proteome in MDCK cells via surface biotinylation followed by SILAC. (A) Flow chart illustrating the procedure for obtaining a polarized surface proteome in MDCK cells. (B) Representative silver-stained gel showing apical and basolateral proteins retrieved after surface biotinylation and background from nonbiotinylated samples. Dividing line indicates noncontiguous gel lanes. (C) SILAC ratios of surface vs. nonbiotinylated proteins. Each data point represents a single protein. Gray datapoints represent proteins from the no biotin sample. Blue datapoints are proteins from the biotinylated sample. Dotted line indicates the −log(10) of a P value = 0.05. (D) Quantification of signal obtained from proteins annotated as plasma membrane or cytoplasmic proteins corrected by total number of proteins in each fraction. (E) Density plot showing percentage frequency of proteins annotated as plasma membrane and cytoplasmic (dark gray) and membrane proteins only (light gray) according to their polarized distribution at the apical and basolateral membrane domains. Ap, apical; BL, basolateral.
Fig. 2.Apical and basolateral proteome of MDCK. (A) Subcellular localization of all 1,737 proteins identified by mass spectrometry (Left), of which 313 were plasma membrane proteins and were classified as apical, basolateral, or not polarized based on the SILAC ratios (Right). (B) Volcano plot of log(2) SILAC ratios for apical vs. basolateral proteins in MDCK cells (horizontal axis) against −log(10) P value (vertical axis). Each data point represents a single protein. Dotted line indicates the −log(10) of a P value = 0.05. Labels indicate proteins of previously known polarized distribution. (C) Validation of a subset of proteins via surface biotinylation followed by Western blot (Left) compared with the percentage detected at the apical and basolateral membranes in proteomics (Right). Ap, apical; BL, basolateral.
Apical and basolateral distribution of surface proteins in MDCK
| Name | Gene identification | Peptides | Sequence coverage (%) | % Apical | % Basolateral | ||
| Basal cell adhesion molecule | BCAM | 28 | 62.9 | 6 | 11 | 89 | 1.16293E-08 |
| Plexin A1 | PLXNA1 | 24 | 9.9 | 6 | 15 | 85 | 4.61961E-06 |
| Plexin B1 | PLXNB1 | 27 | 17.4 | 4 | 12 | 88 | 0.023047413 |
| Semaphorin 4D | SEMA4D | 19 | 7.9 | 4 | 24 | 76 | 0.149175744 |
| Integrin subunit-α6 | ITGA6 | 48 | 47.8 | 6 | 22 | 78 | 0.000253324 |
| Integrin subunit-β1 | ITGB1 | 28 | 42.2 | 6 | 24 | 76 | 0.001229654 |
| Integrin subunit-αV | ITGAV | 61 | 58 | 6 | 25 | 75 | 0.000361996 |
| Integrin subunit-α2 | ITGA2 | 42 | 43.9 | 6 | 29 | 71 | 0.022472422 |
| Insulin-like growth factor 1 receptor | IGF1R | 42 | 37.8 | 6 | 40 | 60 | 0.163886842 |
| Intercellular adhesion molecule 1 | ICAM1 | 9 | 19.5 | 5 | 96 | 4 | 0.017956289 |
| Piezo-type mechanosensitive ion channel component 1 | PIEZO1 | 19 | 8.2 | 5 | 18 | 82 | 0.006293186 |
| Transmembrane and coiled-coil domains 1 | TMCO1 | 2 | 12.2 | 4 | 74 | 26 | 0.170385728 |
| Chloride intracellular channel 1 | CLIC1 | 5 | 27.4 | 6 | 89 | 11 | 0.234170658 |
| Solute carrier family 9 member A1 | SLC9A1 | 9 | 8.7 | 4 | 5 | 95 | 0.016457311 |
| Anoctamin 6 | ANO6 | 25 | 26.6 | 6 | 16 | 84 | 4.74988E-05 |
| Leucine-rich repeat containing 8 VRAC subunit A | LRRC8A | 11 | 12.5 | 4 | 29 | 71 | 0.139840212 |
| Cell migration-inducing hyaluronidase 2 | TMEM2 | 8 | 5.1 | 6 | 27 | 73 | 0.004854648 |
| Pyrophosphatase (inorganic) 1 | PPA1 | 5 | 33.1 | 6 | 86 | 14 | 0.005309926 |
| 2′,3′-Cyclic nucleotide 3′ phosphodiesterase | CNP | 20 | 46.4 | 6 | 87 | 13 | 0.005965224 |
| Prenylcysteine oxidase 1 | PCYOX1 | 8 | 6.5 | 4 | 100 | 0 | 0.01011956 |
| Endonuclease domain containing 1 | ENDOD1 | 7 | 33.7 | 6 | 83 | 17 | 0.004053892 |
| Lamin B receptor | LBR | 13 | 29.1 | 6 | 71 | 29 | 0.096990048 |
| Cadherin 16 | CDH16 | 26 | 46.7 | 4 | 8 | 92 | 0.024358355 |
| Ectonucleoside triphosphate diphosphohydrolase 3 | ENTPD3 | 17 | 34 | 6 | 72 | 28 | 2.3237E-07 |
| Paraoxonase 2 | PON2 | 4 | 18.1 | 6 | 77 | 23 | 0.001226897 |
| Tripartite motif-containing 25 | TRIM25 | 14 | 27.9 | 6 | 70 | 30 | 0.004216133 |
| Lipolysis stimulated lipoprotein receptor | LSR | 20 | 29.3 | 6 | 3 | 97 | 5.49804E-06 |
| Signal transducer and activator of transcription 3 | STAT3 | 18 | 35.3 | 5 | 42 | 58 | 0.169979355 |
| Protein tyrosine phosphatase, receptor type M | PTPRM | 26 | 28.3 | 4 | 22 | 78 | 0.078938671 |
| Protein tyrosine phosphatase, receptor type F | PTPRF | 79 | 64.5 | 6 | 28 | 72 | 6.96458E-05 |
| Calpain 2 | CAPN2 | 40 | 64.9 | 6 | 64 | 36 | 0.134192804 |
| Transmembrane serine protease 4 | TMPRSS4 | 6 | 18.6 | 6 | 13 | 87 | 1.52653E-05 |
| ADAM metallopeptidase domain 17 | ADAM17 | 13 | 21.9 | 6 | 7 | 93 | 9.63391E-05 |
| ADAM metallopeptidase domain 10 | ADAM10 | 20 | 36.7 | 6 | 13 | 87 | 9.53067E-07 |
| Suppression of tumorigenicity 14 | ST14 | 7 | 11 | 5 | 23 | 77 | 0.026355564 |
| Carboxypeptidase M | Cpm | 5 | 12.2 | 5 | 74 | 26 | 0.024747236 |
| Glutamyl aminopeptidase | ENPEP | 30 | 22.6 | 6 | 100 | 0 | 2.70449E-05 |
| Xenotropic and polytropic retrovirus receptor 1 | XPR1 | 7 | 11.2 | 6 | 14 | 86 | 8.78517E-05 |
| Cadherin EGF LAG seven-pass G-type receptor 2 | CELSR2 | 25 | 12.3 | 6 | 19 | 81 | 0.005019663 |
| Adhesion G protein-coupled receptor G1 | ADGRG1 | 4 | 2.5 | 4 | 24 | 76 | 0.13836571 |
| Frizzled class receptor 6 | FZD6 | 8 | 8.6 | 5 | 36 | 64 | 0.128016301 |
| G protein-coupled receptor class C group 5 member A | GPRC5A | 4 | 10.1 | 6 | 87 | 13 | 0.000616634 |
| ATP binding cassette subfamily E member 1 | ABCE1 | 29 | 52 | 6 | 61 | 39 | 0.027707251 |
| ATP binding cassette subfamily F member 1 | ABCF1 | 12 | 21.2 | 6 | 69 | 31 | 0.080170041 |
| Solute carrier family 35 member A1 | SLC35A1 | 4 | 10.7 | 6 | 82 | 18 | 0.02315915 |
| Solute carrier family 44 member 2 | SLC44A2 | 20 | 28.6 | 6 | 8 | 92 | 5.95465E-06 |
| Solute carrier family 39 member 10 | SLC39A10 | 4 | 9.9 | 6 | 26 | 74 | 2.85037E-08 |
| Solute carrier family 4 member 2 | SLC4A2 | 37 | 11.2 | 5 | 8 | 92 | 0.002769117 |
| ATPase Na+/K+-transporting subunit β1 | ATP1B1 | 19 | 46.9 | 6 | 12 | 88 | 1.82896E-10 |
| ATPase Na+/K+-transporting subunit-α1 | ATP1A1 | 71 | 56.7 | 6 | 16 | 84 | 2.21093E-11 |
| Scavenger receptor class B member 1 | SCARB1 | 11 | 22.2 | 6 | 25 | 75 | 0.076726321 |
| ATPase Na+/K+-transporting subunit-β3 | ATP1B3 | 7 | 53.8 | 4 | 25 | 75 | 0.102593542 |
| Hephaestin | HEPH | 23 | 25 | 6 | 26 | 74 | 0.019696101 |
| Polymeric Ig receptor | PIGR | 10 | 18.8 | 6 | 27 | 73 | 0.041687344 |
| Transferrin receptor | TFRC | 32 | 45.3 | 6 | 27 | 73 | 7.07717E-08 |
| Folate receptor-β | FOLR2 | 4 | 23.5 | 6 | 86 | 14 | 0.000183835 |
| Carcinoembryonic antigen-related cell adhesion molecule 1 | CEACAM1 | 16 | 29 | 6 | 93 | 7 | 0.000146391 |
| EPH receptor B4 | EPHB4 | 16 | 22.4 | 6 | 1 | 99 | 0.000591366 |
| EPH receptor A1 | EPHA1 | 17 | 25.3 | 5 | 8 | 92 | 0.003683916 |
| Erb-b2 receptor tyrosine kinase 2 | ERBB2 | 38 | 41.2 | 6 | 13 | 87 | 2.46446E-05 |
| Epidermal growth factor receptor | EGFR | 29 | 31.9 | 6 | 18 | 82 | 2.48095E-05 |
| MET protooncogene, receptor tyrosine kinase | MET | 38 | 36.8 | 6 | 27 | 73 | 0.111350932 |
| Ephrin B1 | EFNB1 | 7 | 37.2 | 6 | 28 | 72 | 0.012405291 |
| Podocalyxin | PODXL | 13 | 24.7 | 6 | 99 | 1 | 9.85873E-10 |
The complete table is in Dataset S1.
Fig. 3.Silencing of the μ1A or μ1B subunits of the AP-1 complex in MDCK cells produces shifts in the polarity of surface proteins. Linear regressions obtained by comparing the apical distribution of control proteins (luciferase siRNA) with (A) μ1A siRNA, (B) μ1B siRNA, and (C) double silencing of μ1A and μ1B simultaneously (μ1A + μ1B). The fitted line indicating the region of no change is represented in red and crosses the origin at x = 0 and y = 0. Protein shifts resulting from loss of apical polarity fall in the quadrant indicated in orange. Protein shifts resulting from loss of basolateral polarity fall in the quadrant indicated in green. A select set of proteins (indicated by name) was identified to verify the results by surface biotinylation and Western blot after silencing of μ1A, μ1B, or both in MDCK cells. Ap, apical; BL, basolateral.
Fig. 4.Selected apical and basolateral proteins affected by silencing the μ1A or μ1B subunits of the AP-1 complex in MDCK cells as measured by surface biotinylation followed by Western blot. The examples provided illustrate basolateral proteins that had reduced polarity after silencing AP-1 subunits (A–F), apical proteins that had reduced polarity after silencing μ1A and μ1B simultaneously (G–I) or individually (J), and an apical (K) and a basolateral protein (L) that were not affected by silencing of μ1A or μ1B. For each protein, we calculated the total surface levels as indicated in A′–L′. Bars represent mean percentage surface distribution ± SD. n = 3–4. Ap, apical; BL, basolateral. *P < 0.05 vs. control (si-Luc) one-way ANOVA with Dunnett’s correction for multiple comparisons against control.
Fig. 5.Global patterns of major shifts in polarity after silencing AP-1A, AP-1B, or both. Volcano plots showing the magnitude of (A) the shifts toward the apical and basolateral sides when silencing μ1A, (B) the shifts when silencing μ1B, and (C) the shifts with the double silencing. Dotted lines represent P = 0.05. Data points above the line are statistically significant. (D) Quantification of the magnitude of shifts toward the apical (positive values) or basolateral (negative values) domains after silencing μ1A (blue), μ1B, (red), or both (green). The lengths of the vectors (radii) are directly proportional to the compounded contribution of the number of proteins affected and the intensity of the shift. (E) Percentages of proteins not affected by silencing of AP-1 subunits or affected by experiencing a shift toward the basolateral or apical sides. Subcharts indicate the proportions of proteins that experienced a shift toward the apical or basolateral side after silencing of the μ-subunits as indicated. Ap, apical; BL, basolateral.